| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |